↓ Skip to main content

Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion gene

Overview of attention for article published in Annals of Hematology, July 2015
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user

Citations

dimensions_citation
53 Dimensions

Readers on

mendeley
32 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion gene
Published in
Annals of Hematology, July 2015
DOI 10.1007/s00277-015-2451-7
Pubmed ID
Authors

Elisa Rumi, Jelena D. Milosevic, Dominik Selleslag, Ilaria Casetti, Els Lierman, Daniela Pietra, Chiara Cavalloni, Marta Bellini, Chiara Milanesi, Irene Dambruoso, Cesare Astori, Robert Kralovics, Peter Vandenberghe, Mario Cazzola

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 32 100%

Demographic breakdown

Readers by professional status Count As %
Other 7 22%
Researcher 4 13%
Professor > Associate Professor 3 9%
Student > Doctoral Student 2 6%
Student > Bachelor 2 6%
Other 7 22%
Unknown 7 22%
Readers by discipline Count As %
Medicine and Dentistry 14 44%
Biochemistry, Genetics and Molecular Biology 3 9%
Computer Science 2 6%
Arts and Humanities 1 3%
Agricultural and Biological Sciences 1 3%
Other 3 9%
Unknown 8 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 December 2015.
All research outputs
#18,432,465
of 22,835,198 outputs
Outputs from Annals of Hematology
#1,445
of 2,168 outputs
Outputs of similar age
#189,515
of 263,751 outputs
Outputs of similar age from Annals of Hematology
#10
of 22 outputs
Altmetric has tracked 22,835,198 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,168 research outputs from this source. They receive a mean Attention Score of 4.1. This one is in the 21st percentile – i.e., 21% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 263,751 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.